Science Explorer Back to mapMap
Discussion
Company · Herndon · United States

Innovative Biologics (United States)

Research works
41
▲ 67% vs 2018-21
Citations
815
20.0 per fractional work
Top-10% rate
13.4%
all institutions 10.0%
Open access
55%
world 40%
International
47%
world 18%

Not ranked overall: Innovative Biologics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Innovative Biologics (United States) work in?

In all years, 57% of research at Innovative Biologics (United States) is in Health Sciences, 28% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (20%), Engineering (8%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 23 fractional works · 57.1% of its workMedicine: 22 fractional works · 54.8% of its workSurgery: 4 fractional works · 10.3% of its workOncology: 3 fractional works · 6.5% of its workPhysiology: 3 fractional works · 6.3% of its workInfectious Diseases: 3 fractional works · 6.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 3.4% of its workRheumatology: 1 fractional works · 2.3% of its workPharmacology: 1 fractional works · 1.8% of its workEpidemiology: 1 fractional works · 1.7% of its workGenetics: 1 fractional works · 1.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.6% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.4% of its workUrology: 1 fractional works · 1.4% of its workAnesthesiology and Pain Medicine: 1 fractional works · 1.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.0% of its workOrthopedics and Sports Medicine: 0 fractional works · 1.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.0% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.8% of its workHepatology: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workOphthalmology: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.6% of its workHealth Informatics: 0 fractional works · 0.3% of its workNephrology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 1 fractional works · 1.4% of its workSmall Animals: 1 fractional works · 1.4% of its workDentistry: 0 fractional works · 0.7% of its workOral Surgery: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.2% of its workLife Sciences: 11 fractional works · 27.7% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 20.0% of its workMolecular Biology: 5 fractional works · 13.2% of its workGenetics: 2 fractional works · 3.7% of its workBiotechnology: 1 fractional works · 1.6% of its workCell Biology: 0 fractional works · 0.5% of its workClinical Biochemistry: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.2% of its workEndocrinology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 5.1% of its workImmunology: 2 fractional works · 4.6% of its workMicrobiology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 1.5% of its workFood Science: 0 fractional works · 1.2% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 12.4% of its workEngineering: 3 fractional works · 8.3% of its workBiomedical Engineering: 2 fractional works · 6.1% of its workAerospace Engineering: 0 fractional works · 0.9% of its workMechanical Engineering: 0 fractional works · 0.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workEnvironmental Science: 1 fractional works · 2.0% of its workEnvironmental Engineering: 0 fractional works · 0.8% of its workEcology: 0 fractional works · 0.7% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.9% of its workSpectroscopy: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.5% of its workSurfaces, Coatings and Films: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.5% of its workStatistics and Probability: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 2.8% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.2% of its workEconomics and Econometrics: 0 fractional works · 1.2% of its workSocial Sciences: 0 fractional works · 1.2% of its workHealth: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKInnovativeBiologics (Unite…41fractional works, all years
Life Sciences28%Physical Sciences12%Health Sciences57%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine2254.8%
    2. Veterinary11.4%
    3. Dentistry00.7%
    4. Health Professions00.2%
    1. Biochemistry, Genetics and Molecular Biology820.0%
    2. Immunology and Microbiology25.1%
    3. Agricultural and Biological Sciences11.5%
    4. Neuroscience00.9%
    5. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Engineering38.3%
    2. Environmental Science12.0%
    3. Chemistry00.9%
    4. Materials Science00.5%
    5. Mathematics00.5%
    6. Computer Science00.2%
    1. Economics, Econometrics and Finance01.2%
    2. Social Sciences01.2%
    3. Decision Sciences00.2%
    4. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.23× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.33× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 5.51× its world share, 1 worksImmunology and Micro…Neuroscience: 0.42× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.54× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.39× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringEnvironmental Science: 0.25× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.29× its world share, 0 worksMaterials ScienceMathematics: 1.11× its world share, 0 worksMathematicsDentistry: 1.79× its world share, 0 worksDentistryHealth Professions: 0.18× its world share, 0 worksHealth ProfessionsMedicine: 3.34× its world share, 10 worksMedicineVeterinary: 2.00× its world share, 0 worksVeterinaryDecision Sciences: 0.32× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.34× its world share, 0 worksEconomics, Econometr…Psychology: 0.13× its world share, 0 worksPsychologySocial Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Immunology and Microbiology5.51×1 works
  2. Medicine3.34×10 works
  3. Biochemistry, Genetics and Molecular Biology3.33×3 works
  4. Veterinary2.00×0 works
  5. Dentistry1.79×0 works
  6. Pharmacology, Toxicology and Pharmaceutics1.54×0 works
  7. Mathematics1.11×0 works
  8. Neuroscience0.42×0 works
  9. Chemistry0.39×0 works
  10. Economics, Econometrics and Finance0.34×0 works
  11. Decision Sciences0.32×0 works
  12. Materials Science0.29×0 works
  13. Environmental Science0.25×0 works
  14. Agricultural and Biological Sciences0.23×0 works
  15. Health Professions0.18×0 works
  16. Engineering0.13×0 works
  17. Psychology0.13×0 works
  18. Social Sciences0.05×0 works
  19. Computer Science0.04×0 works

Who are the top researchers at Innovative Biologics (United States)?

Ranked on the quality score, Vladimir A. Karginov lead among researchers whose main affiliation is Innovative Biologics (United States).

  1. 1 Vladimir A. Karginov United States · #4,978,184 worldwide 1.1k citations · 50 works
All ranked researchers at Innovative Biologics (United States)

What are the most cited papers from Innovative Biologics (United States)?

The most cited paper from Innovative Biologics (United States) is "COVID-19 vaccines: rapid development, implications, challenges and future prospects" (Shivaji Kashte, Arvind Gulbake, Saadiq F. El‐Amin et al., 2021), with 424 citations. Next come "Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses" (131) and "Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design" (118).

Most cited papers
#PaperReleasedCitations
1 COVID-19 vaccines: rapid development, implications, challenges and future prospects Shivaji Kashte, Arvind Gulbake, Saadiq F. El‐Amin et al. · Human Cell Open access 7 Mar 2021 424
2 Blocking FcRn in humans reduces circulating IgG levels and inhibits IgG immune complex–mediated immune responses Laurence Blumberg et al. · Science Advances Open access 6 Dec 2019 131
3 Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design Vladimir A. Karginov, Ekaterina M. Nestorovich, Mahtab Moayeri et al. · Proceedings of the National Academy of Sciences Open access 7 Oct 2005 118
4 Importance of Complement Source in Measuring Meningococcal Bactericidal Titers George França dos Santos, R. Randall Deck, John Donnelly et al. · Clinical and Diagnostic Laboratory Immunology Open access May 2001 115
5 Prevention and Treatment ofStaphylococcus aureusPneumonia with a β-Cyclodextrin Derivative Brook E. Ragle, Vladimir A. Karginov, Juliane Bubeck Wardenburg · Antimicrobial Agents and Chemotherapy Open access 6 Oct 2009 114
All 61 most cited papers, with filters and sorting

Which keywords describe research at Innovative Biologics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Clinical Trials, Epidemiology, Regenerative Medicine, Monoclonal Antibodies, Regulatory Challenges, Stem Cell Regulation, Therapeutic Antibodies and Healthcare-Associated Infections.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology5▲ 3.3×27 topics
  2. Clinical Trials4▲ 17×9 topics
  3. Regenerative Medicine3▲ 36×5 topics
  4. Inflammation2▲ 2.6×12 topics
  5. Monoclonal Antibodies2▲ 42×3 topics
  6. Regulatory Challenges2▲ 68×1 topic
  7. Stem Cell Regulation2▲ 232×1 topic
  8. Therapeutic Antibodies2▲ 38×2 topics
  9. Healthcare-Associated Infections2▲ 39×3 topics
  10. Biopharmaceuticals2▲ 65×3 topics
  11. Glycosylation2▲ 20×3 topics
  12. Regeneration2▲ 23×3 topics
  13. Pathogenesis2▲ 7.1×6 topics
  14. Angiogenesis2▲ 9.2×6 topics
  15. Biomaterials2▲ 19×2 topics
  16. Immunogenicity2▲ 71×2 topics
  17. Mesenchymal Stem Cells2▲ 30×2 topics
  18. Risk Factors1▲ 3.2×6 topics
  19. Tumor Microenvironment1▲ 10×4 topics
  20. Antibiotic Resistance1▲ 7.7×4 topics
  21. Cancer Immunotherapy1▲ 22×3 topics
  22. Extracellular Matrix1▲ 13×5 topics
  23. Recombinant Proteins1▲ 61×2 topics
  24. Bone Regeneration1▲ 26×2 topics
  25. Clinical Practice Guidelines1▲ 4.8×3 topics
  26. Immune Checkpoint Blockade1▲ 49×1 topic
  27. Immunotherapy1▲ 4.3×4 topics
  28. PD-1 and PD-L11▲ 49×1 topic
  29. Revision Surgery1▲ 23×2 topics
  30. Staphylococcus aureus1▲ 35×2 topics
  31. Tissue Engineering1▲ 5.1×5 topics
  32. Total Hip Replacement1▲ 23×2 topics
  33. Vaccine1▲ 6.9×7 topics
  34. Antibody Engineering1▲ 25×1 topic
  35. Clinical Management1▲ 12×2 topics
  36. Education1▲ 1.88×2 topics
  37. Fc Receptors1▲ 25×1 topic
  38. Matrix Metalloproteinases1▲ 16×2 topics
  39. Osteoarthritis1▲ 20×3 topics
  40. Toxins1▲ 21×2 topics

Which research topics does Innovative Biologics (United States) publish most on?

By volume in 2022-now: Osteoarthritis Treatment and Mechanisms, Knee injuries and reconstruction techniques, Shoulder Injury and Treatment and Total Knee Arthroplasty Outcomes.

  1. 1 Osteoarthritis Treatment and Mechanisms Rheumatology 1 works
  2. 2 Knee injuries and reconstruction techniques Surgery 1 works
  3. 3 Shoulder Injury and Treatment Surgery 0 works
  4. 4 Total Knee Arthroplasty Outcomes Surgery 0 works
  5. 5 Biomedical Ethics and Regulation Physiology 0 works
  6. 6 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
  7. 7 Protein purification and stability Molecular Biology 0 works
  8. 8 Periodontal Regeneration and Treatments Urology 0 works
  9. 9 Pain Management and Treatment Anesthesiology and Pain Medicine 0 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.1%not open44.9%

World: 40% of research is openly available.

with international co-authors47.4%domestic only52.6%

World: 18% is written across borders.

How has Innovative Biologics (United States)'s research output changed?

Output in 2022-2025 was 67% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Innovative Biologics (United States) as a percentage of every work published that year, 0.000099% in 2024.

still counting0.000050%0.00010%0.00015%Innovative Biologics (United States)0.000046% in 2025200020102020

Fractional works of Innovative Biologics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Herndon

All research institutions in Herndon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Innovative Biologics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.